RE: CURRENT COST OF DEMENTIA IN U.K. AND GLOBALLY WE ARE DEVELOPING THE WORLDS FIRST ACCURATE TEST14 Jun 2021 12:38
MSVISION
The first fully assembled instrument, incorporating Paraytec's detector technology, has been produced by MS Vision and shipped to Karolinska Institute in Sweden for testing. The instrument uses capillary isoelectric focusing (cIEF), together with ActiPix technology, to measure the level of protein biomarkers (abnormal proteoforms) in blood samples. If present, these biomarkers are indicative of the likely rate of mental decline for a given AD patient. This is important because such information could be used by clinicians in early diagnosis to differentiate AD patients from those with mild cognitive impairment, and also by researchers to help develop better drugs to counter this devastating disease.
Link to MS Vision website
https://msvision.com
StarKnight